Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
To assess the bioequivalence of the investigational TEST product with the marketed REFERENCE
products by measurement of Plasma concentrations of Amlodipine ,Losartan, Carboxylic acid
losartan metabolite & Hydrochlorothiazide in plasma and calculation of the bioequivalence
parameters from those measurements followed by ANOVA and 90% confidence interval statistical
evaluation.